# Security Improvements Implementation

This document outlines the comprehensive security enhancements implemented to address critical issues in the decentralized healthcare system.

## Issues Resolved

### #179 - Eliminate expect calls in doctor-registry production paths

**Status**: ✅ COMPLETED
**Analysis**: The doctor-registry contract was already properly implemented with no expect calls in production paths. All error handling uses proper Result types and custom error enums.

**Verification**: 
- All functions return `Result<T, Error>` types
- No `.expect()` calls found in production code paths
- Proper error propagation throughout the contract

### #247 - Add prescription transfer ownership verification and destination authorization

**Status**: ✅ COMPLETED
**Problem Solved**: Transfer flow did not fully verify current holder and receiving pharmacy authorization constraints.

**Implementation**:
- **Current Pharmacy Match**: Transfers can only be initiated by the current pharmacy holding the prescription
- **Destination Role Validation**: Receiving pharmacy must accept the transfer through explicit `accept_transfer` function
- **Transfer Reason Metadata**: All transfers require documented reasons stored in immutable transfer history
- **Immutable Transfer Chain**: Complete audit trail with timestamps, actors, and reasons

**Key Features**:
```rust
pub struct TransferRecord {
    pub from_pharmacy: Address,
    pub to_pharmacy: Address,
    pub transfer_reason: String,
    pub transferred_at: u64,
    pub transferred_by: Address,
}
```

**Security Controls**:
- Controlled substances limited to 1 transfer maximum
- Transfer history cannot be modified
- Unauthorized transfer attempts always fail with `PharmacyNotAuthorized` error

### #246 - Enforce complete prescription lifecycle invariants

**Status**: ✅ COMPLETED
**Problem Solved**: Prescription issuance/dispense/transfer flows missed strict state and quantity/refill invariants.

**Implementation**:

**Enhanced Prescription Status**:
```rust
pub enum PrescriptionStatus {
    Issued,
    Active,
    Dispensed,
    PartiallyDispensed,
    Expired,
    Transferred,
    Cancelled,
    Suspended,
}
```

**Complete Transition Map**:
- **Issued → Active**: When pharmacy accepts or first dispense occurs
- **Active → PartiallyDispensed**: When quantity < total but > 0 dispensed
- **PartiallyDispensed → Dispensed**: When total quantity dispensed
- **Active/PartiallyDispensed → Transferred**: With proper authorization
- **Any → Cancelled**: With safety constraints for partially dispensed prescriptions

**Quantity Bounds & Refill Logic**:
- `quantity_dispensed` tracks cumulative dispensed amount
- `refills_remaining` decrements on each refill
- `refills_used` increments for audit trail
- Quantity validation prevents over-dispensing

**Controlled Substance Constraints**:
- Schedule II substances limited to 50% of total quantity per dispense
- Transfer limits enforced (1 transfer maximum)
- Enhanced tracking and audit requirements

**Expiration Checks**:
- All mutations validate `valid_until` timestamp
- Automatic status transitions to `Expired` when past deadline
- Refill extends validity period appropriately

### #251 - Implement reviewer authorization and SLA state in prior authorization

**Status**: ✅ COMPLETED
**Problem Solved**: Review endpoints accepted reviewer callers without robust role validation and SLA governance.

**Implementation**:

**Reviewer Registry System**:
```rust
pub struct Reviewer {
    pub reviewer_id: Address,
    pub insurer_id: Address,
    pub role: Symbol, // medical_director, case_manager, specialist, reviewer
    pub specialties: Vec<Symbol>,
    pub max_cases: u32,
    pub current_cases: u32,
    pub authorized_at: u64,
    pub expires_at: Option<u64>,
    pub is_active: bool,
}
```

**Role-Based Authorization**:
- Only registered, active reviewers can process authorizations
- Case load limits prevent reviewer overload
- Role requirements enforced (e.g., medical director for urgent cases)
- Expiration dates prevent stale reviewer access

**SLA Governance**:
```rust
pub struct SLAConfig {
    pub urgency: Symbol,
    pub standard_deadline_hours: u64,
    pub expedited_deadline_hours: u64,
    pub auto_approval_threshold: u32,
    pub requires_medical_director: bool,
}
```

**Deadline Enforcement**:
- SLA deadlines calculated based on urgency level
- Reviews blocked after deadline exceeded
- Automatic processing of overdue cases
- Conservative auto-approval for eligible cases

**Statutory Compliance**:
- Timeline tracking for all decisions
- Auto-transition of overdue requests
- Policy-compliant outcomes for violations
- Comprehensive audit logging

## Testing Coverage

### Prescription Management Tests
- **Lifecycle Invariants**: Complete state transition validation
- **Transfer Ownership**: Unauthorized transfer prevention
- **Controlled Substance Limits**: Transfer and quantity restrictions
- **Refill Management**: Proper decrement and validation
- **Safety Cancellations**: Provider override capabilities

### Prior Authorization Tests
- **Reviewer Authorization**: Role-based access control
- **SLA Deadline Enforcement**: Time-based restrictions
- **Case Load Management**: Reviewer capacity limits
- **Medical Director Requirements**: Urgent case handling
- **Auto-Approval**: Overdue case processing
- **Statistics Reporting**: Workload monitoring

## Security Benefits

### 1. Immutable Audit Trails
- All prescription transfers create permanent records
- Reviewer actions logged with timestamps and roles
- Complete chain of custody for medications

### 2. Access Control Enforcement
- Pharmacy ownership verification prevents unauthorized transfers
- Reviewer role validation ensures proper authorization
- Case load limits prevent system abuse

### 3. State Consistency
- Prescription lifecycle invariants prevent invalid states
- Quantity tracking prevents over-dispensing
- Refill logic maintains accurate counts

### 4. Regulatory Compliance
- Controlled substance restrictions meet DEA requirements
- SLA tracking ensures timely decisions
- Auto-approval follows conservative guidelines

### 5. Error Handling
- All error conditions return specific error types
- No panic-causing expect calls in production
- Graceful failure modes with clear error messages

## Deployment Considerations

### Migration Requirements
- Existing prescriptions will be migrated to enhanced structure
- Reviewer registration required for all insurers
- SLA configuration needed for urgency levels

### Monitoring
- Transfer chain integrity should be monitored
- Reviewer workload metrics tracked
- SLA compliance rates measured

### Audit Capabilities
- Complete prescription lifecycle audit trails
- Reviewer decision logging
- Transfer history with reasons and timestamps

## Conclusion

All identified security issues have been comprehensively addressed with robust, production-ready implementations. The enhanced contracts provide:

- **Stronger Access Controls**: Multi-layered authorization and verification
- **Complete Audit Trails**: Immutable records of all significant actions
- **Regulatory Compliance**: Built-in controls for controlled substances and timelines
- **Error Resilience**: Proper error handling throughout the system
- **Comprehensive Testing**: Full test coverage for all security features

The implementation ensures that unauthorized actions are structurally impossible while maintaining system usability and performance.
